Researchers track survival in rare virus-linked cancers
NCT ID NCT05237245
Summary
This study follows patients infected with HTLV-1 virus to understand their long-term survival. It tracks two groups: those who develop a serious blood cancer (ATL) and those who don't. Researchers will collect detailed medical information over time to learn how the disease progresses and responds to treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HTLV-1 INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Necker Enfants Malades
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.